MRNA in the 13F filings
Moderna Inc · CUSIP 60770K107
- Quarter end
- 31 Mar 2025
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 7 May 2025
- Managers listing it
- 11
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q4 2024 and Q1 2025; 8 listed it in both
- Shares listed
- 68,959,574
- combined, among listed positions
- Reported value
- $2.0bn
- combined, at the quarter end
Among the 95 comparable managers: 9 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing MRNA in Q1 2025
11 of 11 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Baillie Gifford & Co | 24,948,558 | $707m | 0.62% | Trimmed | -13,941,013 | 7 May 2025 (the filing on sec.gov) |
| Fidelity (FMR LLC) | 21,130,029 | $599m | under 0.1% | Added | +2,465,395 | 5 Nov 2026 (the filing on sec.gov) |
| D. E. Shaw & Co. | 5,636,151 | $160m | 0.14% | Added | +3,867,436 | 15 May 2025 (the filing on sec.gov) |
| Two Sigma Investments LP | 4,454,103 | $126m | 0.27% | Added | +3,790,063 | 15 May 2025 (the filing on sec.gov) |
| Two Sigma Advisers LP | 3,808,500 | $108m | 0.24% | Added | n.a. | 15 May 2025 (the filing on sec.gov) |
| Jane Street Group LLC | 3,588,037 | $102m | under 0.1% | Trimmed | -27,023 | 19 May 2025 (the filing on sec.gov) |
| Voloridge Investment Management LLC | 3,260,546 | $92m | 0.34% | Added | +669,715 | 15 May 2025 (the filing on sec.gov) |
| Renaissance Technologies LLC | 1,360,100 | $39m | 0.06% | Added | +349,342 | 14 May 2025 (the filing on sec.gov) |
| Walleye Capital LLC | 310,223 | $8.8m | under 0.1% | Added | n.a. | 14 May 2025 (the filing on sec.gov) |
| Woodline Partners LP | 244,332 | $6.9m | under 0.1% | Added | +101,809 | 15 May 2025 (the filing on sec.gov) |
| PDT Partners LLC | 218,995 | $6.2m | 0.44% | Added | n.a. | 15 May 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- D. E. Shaw & Co.existing position · 5,636,151 shares now+3,867,436
- Two Sigma Investments LPexisting position · 4,454,103 shares now+3,790,063
- Fidelity (FMR LLC)existing position · 21,130,029 shares now+2,465,395
- Voloridge Investment Management LLCexisting position · 3,260,546 shares now+669,715
- Renaissance Technologies LLCexisting position · 1,360,100 shares now+349,342
Reductions
- Baillie Gifford & Coexisting position · 24,948,558 shares now-13,941,013
- Jane Street Group LLCexisting position · 3,588,037 shares now-27,023
New positions and exits
New (0)
No new position among listed positions.
Exited (2)
- Bridgewater Associates LPwas $25m
- Coatue Management LLCwas $7.9m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2018 | 2 | $287m | n.a. | n.a. |
| Q1 2019 | 3 | $688m | n.a. | n.a. |
| Q2 2019 | 2 | $167m | n.a. | n.a. |
| Q3 2019 | 2 | $126m | n.a. | n.a. |
| Q4 2019 | 5 | $449m | n.a. | n.a. |
| Q1 2020 | 8 | $1.0bn | n.a. | n.a. |
| Q2 2020 | 9 | $3.1bn | n.a. | n.a. |
| Q3 2020 | 6 | $3.1bn | n.a. | n.a. |
| Q4 2020 | 16 | $4.4bn | n.a. | n.a. |
| Q1 2021 | 18 | $8.0bn | n.a. | n.a. |
| Q2 2021 | 22 | $18.4bn | n.a. | n.a. |
| Q3 2021 | 27 | $27.6bn | n.a. | n.a. |
| Q4 2021 | 20 | $17.2bn | n.a. | n.a. |
| Q1 2022 | 16 | $11.8bn | n.a. | n.a. |
| Q2 2022 | 19 | $10.2bn | n.a. | n.a. |
| Q3 2022 | 22 | $8.4bn | n.a. | n.a. |
| Q4 2022 | 20 | $13.0bn | n.a. | n.a. |
| Q1 2023 | 17 | $11.2bn | n.a. | n.a. |
| Q2 2023 | 15 | $8.9bn | n.a. | n.a. |
| Q3 2023 | 12 | $7.2bn | n.a. | n.a. |
| Q4 2023 | 8 | $6.9bn | 5 | 5 |
| Q1 2024 | 7 | $7.6bn | 3 | 5 |
| Q2 2024 | 13 | $9.5bn | 9 | 4 |
| Q3 2024 | 12 | $4.8bn | 9 | 4 |
| Q4 2024 | 15 | $3.1bn | 13 | 3 |
| Q1 2025 | 11 | $2.0bn | 9 | 4 |
| Q2 2025 | 10 | $2.0bn | 7 | 3 |
| Q3 2025 | 9 | $1.2bn | 5 | 4 |
| Q4 2025 | 10 | $2.5bn | 16 | 20 |
| Q1 2026 | 9 | $4.8bn | 17 | 19 |
| Q2 2026 | 9 | $8.0bn | 17 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MRNA and GILD →MRNA and AMGN →MRNA and ARGX →Choose a stock to compare with MRNA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MRNA, latest filings →Back to the 13F Explorer →